Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Ramirez

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Ochsner Journal|September 27, 2021
A Peptide Meets a Radionuclide to Combat a Rare TumorKatharine E Thomas, J Philip Boudreaux, Ramcharan Thiagarajan, et al.
Annals of Surgical Oncology|July 22, 2020
Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small TumorsJace P Landry, Brianne A Voros, Robert A Ramirez, et al.
The Oncologist|May 27, 2016
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine TumorsRobert A Ramirez, David T Beyer, Aman Chauhan, et al.
Journal of Thoracic Disease|November 18, 2024
The optimal stereotactic body radiotherapy dose with immunotherapy for pulmonary oligometastases: a retrospective cohort studyXiajing Qian, Zhengxuying Fang, Wei Jiang, et al.
The Oncologist|January 13, 2019
Current Treatment Options in Gastroenteropancreatic Neuroendocrine CarcinomaKatharine E H Thomas, Brianne A Voros, J Philip Boudreaux, et al.
Pancreas|February 16, 2019
Plasma Pancreastatin Predicts the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small BowelEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Cancer Research|August 3, 2002
Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acidPatricia A Masso-Welch, Danilo Zangani, Clement Ip, et al.
The Oncologist|May 6, 2020
A Neuroendocrine Tumor Specialty Center in New Orleans' (NOLANETS) Response to Patient Care During the COVID-19 PandemicRobert A Ramirez, Yvette Bren-Mattison, Ramcharan Thiagarajan, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinomaZhen Lin, Yue-Yun Chen, Chun-Hua Liu, et al.
Journal of the American College of Surgeons|February 1, 2016
Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the DuodenumEugene A Woltering, David T Beyer, Ramcharan Thiagarajan, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Ochsner Journal|September 27, 2021
A Peptide Meets a Radionuclide to Combat a Rare TumorKatharine E Thomas, J Philip Boudreaux, Ramcharan Thiagarajan, et al.
Annals of Surgical Oncology|July 22, 2020
Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small TumorsJace P Landry, Brianne A Voros, Robert A Ramirez, et al.
The Oncologist|May 27, 2016
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine TumorsRobert A Ramirez, David T Beyer, Aman Chauhan, et al.
Journal of Thoracic Disease|November 18, 2024
The optimal stereotactic body radiotherapy dose with immunotherapy for pulmonary oligometastases: a retrospective cohort studyXiajing Qian, Zhengxuying Fang, Wei Jiang, et al.
The Oncologist|January 13, 2019
Current Treatment Options in Gastroenteropancreatic Neuroendocrine CarcinomaKatharine E H Thomas, Brianne A Voros, J Philip Boudreaux, et al.
Pancreas|February 16, 2019
Plasma Pancreastatin Predicts the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small BowelEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Cancer Research|August 3, 2002
Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acidPatricia A Masso-Welch, Danilo Zangani, Clement Ip, et al.
The Oncologist|May 6, 2020
A Neuroendocrine Tumor Specialty Center in New Orleans' (NOLANETS) Response to Patient Care During the COVID-19 PandemicRobert A Ramirez, Yvette Bren-Mattison, Ramcharan Thiagarajan, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinomaZhen Lin, Yue-Yun Chen, Chun-Hua Liu, et al.
Journal of the American College of Surgeons|February 1, 2016
Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the DuodenumEugene A Woltering, David T Beyer, Ramcharan Thiagarajan, et al.
Pageof 6